Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Argen X SE (ARGX)
  7. News

ARGX

Argen X SE
342.90
3.60 (1.06%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Argen X SE ARGX Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
3.60 1.06% 342.90 11:40:00
Open Price Low Price High Price Close Price Prev Close
339.30 339.00 344.40 342.90 339.30
more quote information »

Recent News

Date Time Source Heading
1/27/202301:00GLOBEargenx Receives Notification of PDUFA Date Extension for SC..
1/16/202313:30GLOBEargenx Announces Extraordinary General Meeting of..
1/09/202301:00GLOBEargenx Highlights 2023 Strategic Priorities Across..
1/03/202301:00GLOBEargenx to Present at 41st Annual J.P. Morgan Healthcare..
12/12/202216:01GLOBEargenx Appoints Ana Cespedes to Board of Directors
12/10/202211:30GLOBEargenx to Present Pivotal ADVANCE Trial Data During ASH..
11/30/202201:00GLOBEargenx Enters Into Agreement To Acquire Priority Review..
11/22/202201:00GLOBEargenx Announces U.S. FDA Acceptance of Biologics License..
11/07/202201:00GLOBEargenx to Present at Upcoming Investor Conferences
10/27/202201:00GLOBEargenx Reports Third Quarter 2022 Financial Results and..
10/20/202201:00GLOBEargenx to Report Third Quarter 2022 Financial Results and..
9/21/202201:00GLOBEargenx Submits Biologics License Application to U.S. Food..
9/08/202214:10GLOBEargenx Appoints Camilla Sylvest to Board of Directors
8/31/202201:00GLOBEargenx to Present at Wells Fargo Healthcare Conference
8/11/202207:00GLOBEargenx Announces European Commission Approval of VYVGART™..
7/28/202202:30GLOBEargenx announces Extraordinary General Meeting of..
7/28/202201:00GLOBEargenx Reports Half Year 2022 Financial Results and Provides..
7/21/202201:00GLOBEargenx to Report Half Year 2022 Financial Results and Second..
6/24/202201:00GLOBEargenx Receives Positive CHMP Opinion for Efgartigimod for..
6/01/202201:00GLOBEargenx to Present at Upcoming Investor Conferences
5/31/202201:00GLOBEargenx Announces the UK MHRA has Granted Early Access to..
5/19/202207:00GLOBEargenx Announces Publication of Translational Data of..
5/10/202217:30GLOBEargenx announces results of Annual General Meeting of..
5/05/202201:00GLOBEargenx Announces Positive Phase 3 Data from ADVANCE Trial of..
5/04/202201:00GLOBEargenx to Present at BofA Securities 2022 Healthcare..
4/28/202201:00GLOBEargenx to Report First Quarter 2022 Financial Results and..
4/05/202201:00GLOBEargenx Presents Interim Results from ADAPT+ Open-Label..
3/29/202217:00GLOBEargenx announces full exercise of underwriters’ option to..
3/29/202216:30GLOBEargenx announces Annual General Meeting of Shareholders on..
3/28/202216:30GLOBEargenx announces closing of global offering
3/23/202221:00GLOBEargenx raises $700 million in gross proceeds in a global..
3/22/202216:15GLOBEargenx announces launch of proposed global offering
3/03/202201:00GLOBEargenx Reports Full Year 2021 Financial Results and Provides..
2/28/202201:00GLOBEargenx to Present at the 42nd Annual Cowen Health Care..
2/24/202201:00GLOBEargenx to Report Full Year 2021 Financial Results and Fourth..
2/10/202201:00GLOBEargenx to Present at the 11th Annual SVB Leerink Global..